Preliminary Results Of A Multicenter Randomized Phase Ii Trial Of Two Different Combinations Of Docetaxel (D) And Gemcitabine (G) And Of Cisplatin/Gemcitabine (Cg) Followed By Docetaxel As First Line Therapy For Locally Advanced Or Metastatic Non Small Cell Lung Cancer (Nsclc).